RC 344
Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving system at Medical City Dallas
Dallas, TX
Reported pricing
Low
$0
Average
$35.2k
Median
$81
High
$7433.3k
Aggregated across all available billing methodologies for this code.
Last updated: Mar 1, 2026
Compare to other hospitals
See Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving system pricing across every hospital in the network reporting it, or ask Claude or any MCP client directly — see how to connect.